메뉴 건너뛰기
American Journal of Respiratory and Critical Care Medicine
Volumn 189, Issue 3, 2014, Pages 360-361
Reply: Pharmacological obfuscation of clinical relevance
Author keywords

[No Author keywords available]
Indexed keywords

ARGININE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; NADOLOL; PLACEBO; PROPRANOLOL;
EID: 84893546398     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201306-1166LE     Document Type: Letter
Times cited : (2)
References (7)
  • 1
    • 84879595949 scopus 로고    scopus 로고
    • Randomized placebo-controlled trial to evaluate chronic dosing effects of propranolol in asthma
    • Short PM, Williamson PA, Anderson WJ, Lipworth BJ. Randomized placebo-controlled trial to evaluate chronic dosing effects of propranolol in asthma. Am J Respir Crit Care Med 2013;187: 1308-1314.
    • (2013) Am J Respir Crit Care Med , vol.187 , pp. 1308-1314
    • Short, P.M.1    Williamson, P.A.2    Anderson, W.J.3    Lipworth, B.J.4
  • 3
    • 84855398689 scopus 로고    scopus 로고
    • 2-adrenergic receptor signaling pluridimensionality and allow classification of ligands with distinct signaling profiles
    • 2-adrenergic receptor signaling pluridimensionality and allow classification of ligands with distinct signaling profiles. PLoS ONE 2012;7:e29420.
    • (2012) PLoS ONE , vol.7
    • Stallaert, W.1    Dorn, J.F.2    Van Der Westhuizen, E.3    Audet, M.4    Bouvier, M.5
  • 4
    • 70449652591 scopus 로고    scopus 로고
    • Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): A genotype-stratified, randomised, placebo-controlled, crossover trial
    • National Heart, Lung and Blood Institute's Asthma Clinical Research Network
    • Wechsler ME, Kunselman SJ, Chinchilli VM, Bleecker E, Boushey HA, Calhoun WJ, Ameredes BT, Castro M, Craig TJ, Denlinger L, et al.; National Heart, Lung and Blood Institute's Asthma Clinical Research Network. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet 2009;374:1754-1764.
    • (2009) Lancet , vol.374 , pp. 1754-1764
    • Wechsler, M.E.1    Kunselman, S.J.2    Chinchilli, V.M.3    Bleecker, E.4    Boushey, H.A.5    Calhoun, W.J.6    Ameredes, B.T.7    Castro, M.8    Craig, T.J.9    Denlinger, L.10
  • 5
    • 0347319054 scopus 로고    scopus 로고
    • The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol
    • Lee DK, Currie GP, Hall IP, Lima JJ, Lipworth BJ. The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. Br J Clin Pharmacol 2004;57:68-75.
    • (2004) Br J Clin Pharmacol , vol.57 , pp. 68-75
    • Lee, D.K.1    Currie, G.P.2    Hall, I.P.3    Lima, J.J.4    Lipworth, B.J.5
  • 6
    • 0345735773 scopus 로고    scopus 로고
    • Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling
    • Baker JG, Hall IP, Hill SJ. Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling. Mol Pharmacol 2003; 64:1357-1369.
    • (2003) Mol Pharmacol , vol.64 , pp. 1357-1369
    • Baker, J.G.1    Hall, I.P.2    Hill, S.J.3
  • 7
    • 58149178692 scopus 로고    scopus 로고
    • Beta blockers for asthma: A double-edged sword
    • Lipworth BJ, Williamson PA. Beta blockers for asthma: a double-edged sword. Lancet 2009;373:104-105.
    • (2009) Lancet , vol.373 , pp. 104-105
    • Lipworth, B.J.1    Williamson, P.A.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.